Paige: Andy Moye, Jill Stefanelli

Paige has appointed Andy Moye its CEO and Jill Stefanelli its president and chief business officer. Moye was previously Paige's chief commercial officer. Before that, he was head of commercial operations in North America and Latin America for the digital and computational pathology division of Philips. He has also held executive roles in McKesson division Ontada, Caris Life Sciences, and WaferGen Biosystems, now part of Takara Bio.

Stefanelli was previously chief precision medicine officer at Paige. Before that, she was SVP of partnership at Invitae after that firm acquired ArcherDx. She also was at Thermo Fisher Scientific and at Roche Diagnostics and Pacific Biosciences.